NCT04971759View on ClinicalTrials.gov

Dexmedetomidine to Levobupivacaine for Transversus Abdominis Plane Block in Elderly Patients Undergoing Inguinal Hernia Repair Surgery

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

December 1, 2019

Primary Completion Date

December 30, 2020

Study Completion Date

February 1, 2021

Conditions
DexmedetomidineFentanyl
Interventions
DRUG

Levobupivacaine

Levobupivacaine 5%

DRUG

Dexmedetomidine Hydrochloride

Levobupivacaine 5% + 1 µg/kg dexmedetomidine.

DRUG

Fentanyl

Levobupivacaine 5% + 1µg/kg fentanyl

Trial Locations (1)

Unknown

Assiut governorate, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT04971759 - Dexmedetomidine to Levobupivacaine for Transversus Abdominis Plane Block in Elderly Patients Undergoing Inguinal Hernia Repair Surgery | Biotech Hunter | Biotech Hunter